Regenxbio (RGNX) Cash & Current Investments (2014 - 2026)
Regenxbio (RGNX) recorded Cash & Current Investments of $105.52 million in Q2 2026, down 67.4% from $323.3 million a year earlier.
Powered by 
Analysis
Regenxbio (RGNX) Cash & Current Investments (2014 - 2026) Analysis & Trends
At the end of FY2025, Regenxbio reported Cash & Current Investments of $230.07 million, down 2.0% from FY2024.
- Annual Cash & Current Investments has declined for five straight years, with a five-year compound annual growth rate of -13.5% (FY2020 to FY2025).
- Across earlier years, Cash & Current Investments came in at $234.69 million in FY2024 (-14.7%), $275.26 million in FY2023 (-24.5%), $364.64 million in FY2022 (-20.3%) and $457.44 million in FY2021 (-3.8%).
- The Q2 2026 figure is the lowest quarterly Cash & Current Investments since Q4 2016.
- On a year-over-year basis, Cash & Current Investments rose in two of the last seven quarters, with an average decline of 14.5%.
- Peak year-over-year performance for Cash & Current Investments in the last five years was growth of 40.7% in Q3 2021, against a decline of 67.4% in Q2 2026 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.76 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 9.92 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.97 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Regenxbio | 402.44 Mn | -530.65 Mn | - | 105.52 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 105.52 Mn |
| Dec 31, 2025 | 230.07 Mn |
| Sep 30, 2025 | 274.21 Mn |
| Jun 30, 2025 | 323.30 Mn |
| Mar 31, 2025 | 267.87 Mn |
| Dec 31, 2024 | 234.69 Mn |
| Sep 30, 2024 | 255.46 Mn |
| Jun 30, 2024 | 290.36 Mn |
| Mar 31, 2024 | 338.70 Mn |
| Dec 31, 2023 | 275.26 Mn |
| Sep 30, 2023 | 301.89 Mn |
| Jun 30, 2023 | 320.08 Mn |
| Mar 31, 2023 | 331.82 Mn |
| Dec 31, 2022 | 364.64 Mn |
| Sep 30, 2022 | 382.42 Mn |
| Jun 30, 2022 | 402.96 Mn |
| Mar 31, 2022 | 394.13 Mn |
| Dec 31, 2021 | 457.44 Mn |
| Sep 30, 2021 | 339.86 Mn |
| Jun 30, 2021 | 374.74 Mn |
API Access
Regenxbio Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=RGNX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "RGNX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=RGNX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();